original cancer report of a patient

Are the papers published in cancer reports open access?

As of August 13th, 2020, all papers accepted in Cancer Reports are published as Open Access. Authors of accepted papers pay an Article Publication Charge and their papers are published under a Creative Commons license. With Creative Commons licenses, the author retains copyright and the public is allowed to reuse the content.

Who is the publisher of cancer reports?

Wiley Periodicals, LLC. Cancer Reports is a peer-reviewed, international, open access journal covering basic, translational, clinical and interdisciplinary cancer research. Read more here. We are pleased to share that Cancer Reports has been accepted for inclusion in MEDLINE/PubMed, ESCI, and DOAJ.

What is a physician history of cancer?

Physicians often use the connotation of ‘history of,’ meaning that the patient has a past medical history of cancer (which is often still active and being treated when documented this way).

How do I write the author contributions section for cancer reports?

Author Contribution: The role of each author must be described in under this section after the Acknowledgements. Cancer Reports proudly endorses the "CRediT" taxonomy of contributor roles (Brand et al., 2015). We require authors to use this taxonomy when writing the Author Contributions section for research papers and reviews.

How can I check my cancer report?

A pathology report is a medical document that gives information about a diagnosis, such as cancer. To test for the disease, a sample of your suspicious tissue is sent to a lab. A doctor called a pathologist studies it under a microscope. They may also do tests to get more information.

When was the first report of cancer?

The First Documented Case of Cancer The world's oldest documented case of cancer was found on papers (papyrus) from ancient Egypt in 1500 BC. 2 It talked about a tumor found in the breast. The cancer was treated by destroying the tissue with a hot instrument called "the fire drill." Today, we call this "cauterization."

What is a personal history of cancer?

A personal history may include information about allergies, illnesses, surgeries, immunizations, and results of physical exams, tests, and screenings. It may also include information about medicines taken and health habits, such as diet and exercise.

Do doctors have to report cancer?

Reporting Requirements California Law does not require written or verbal patient consent to report, and specifically exempts physicians from any legal action or damages from meeting their legal obligation to report cancer cases or to provide access to those patient's medical records.

Who created cancer?

The origin of the word cancer is credited to the Greek physician Hippocrates (460-370 BC), who is considered the “Father of Medicine.” Hippocrates used the terms carcinos and carcinoma to describe non-ulcer forming and ulcer-forming tumors.

What are 3 facts about cancer?

Key Cancer Facts10 million people die from cancer every year.At least one third of common cancers are preventable.Cancer is the second-leading cause of death worldwide.70% of cancer deaths occur in low-to-middle income countries.More items...

How do you write a personal history?

Writing your personal history is important for future generations to know who you are....Article HighlightsEveryone has stories to tell.When writing a personal record, write as if you are talking to someone.Use interesting, descriptive, sensitive words to bring readers into the story and help them make a connection.

Why is personal history important?

It is a chance to look at your life and see that your life is one well-lived and to see that you have overcome triumphs, celebrated joys and survived heartaches. And not only is it therapeutic for you, it will be for countless generations after you are no longer here.

What is an active cancer?

“Active cancer” is defined as cancer not received potentially curative treatment, or when there is evidence that treatment has not been curative (e.g., recurrent or progressive disease), or when treatment is ongoing [33].

Who tells a patient they have cancer?

Surveys have shown that doctors rank discussing a recurrence of cancer with patients as one of the most difficult tasks they perform. Telling a patient that he or she has cancer for the first time is easier for most doctors because they can usually offer hope in the form of treatment options.

What is the best scan to detect cancer?

A CT scan (also known as a computed tomography scan, CAT scan, and spiral or helical CT) can help doctors find cancer and show things like a tumor's shape and size. CT scans are most often an outpatient procedure. The scan is painless and takes about 10 to 30 minutes.

How can a blood test detect cancer?

Some blood tests used to diagnose cancer include: A test to count your blood cells. A complete blood count (CBC) measures the amount of each type of blood cell in a sample of your blood. Blood cancers may be found using this test.

What is a pathology report?

Stages of Cancer . A pathology report is a medical document that gives information about a diagnosis, such as cancer. To test for the disease, a sample of your suspicious tissue is sent to a lab. A doctor called a pathologist studies it under a microscope. They may also do tests to get more information.

What is the stage of cancer?

Cancer stage: Staging helps your doctor decide what treatments will work best. The most common staging system is the TNM system where the T describes the original cancer, the N states if the cancer has spead to nearby lymph nodes and the M states if the cancer has spread to other parts of the body.Most cancers are assigned an overall stage with a Roman numeral I-IV (1 to 4) based on where it is and how big it is, how far it has spread, and other findings. The higher the stage, the more advanced the cancer. Some cancers have a stage 0, which means it’s an early-stage cancer that has not spread.

What is the margin of a tumor?

Tumor margin: For the pathology sample, your surgeon took out an extra area of normal tissue that surrounds the tumor. This is called the margin. The pathologist will study this area to see if it’s free of cancer cells. There are three possible results:

What does grade mean in cancer?

Grade: The pathologist compares the cancer cells to healthy cells. There are different scales for specific cancers. A tumor grade reflects how likely it is to grow and spread. In general, this is what those grades mean: Grade 1: Low grade, or well-differentiated: The cells look a little different than regular cells.

How to grade a tumor?

Grade: The pathologist compares the cancer cells to healthy cells. There are different scales for specific cancers. A tumor grade reflects how likely it is to grow and spread. In general, this is what those grades mean: 1 Grade 1: Low grade, or well-differentiated: The cells look a little different than regular cells. They aren’t growing quickly. 2 Grade 2: Moderate grade, or moderately differentiated: They don’t look like normal cells. They’re growing faster than normal. 3 Grade 3: High grade, or poorly differentiated: The cells look very different than normal cells. They’re growing or spreading fast.

What is the identifying information on a blood test?

Identifying information: This has your name, birth date, and medical record number. It also lists contact information for your doctor, the pathologist and lab where the sample was tested.

What is the mitotic rate of cancer?

They’re positive if they have cancer and negative if they don’t. Mitotic rate: This is a measure of how quickly cancerous cells are dividing. To get this number, the pathologist usually counts the number of dividing cells in a certain amount of tissue. The mitotic rate is often used to find what stage the cancer is in.

What is the ICd 10 code for cancer?

For more context, consider the meanings of “current” and “history of” (ICD-10-CM Official Guidelines for Coding and Reporting; Mayo Clinic; Medline Plus, National Cancer Institute):#N#Current: Cancer is coded as current if the record clearly states active treatment is for the purpose of curing or palliating cancer, or states cancer is present but unresponsive to treatment; the current treatment plan is observation or watchful waiting; or the patient refused treatment.#N#In Remission: The National Cancer Institute defines in remission as: “A decrease in or disappearance of signs or symptoms of cancer. Partial remission, some but not all signs and symptoms of cancer have disappeared. Complete remission, all signs and symptoms of cancer have disappeared, although cancer still may be in the body.”#N#Some providers say that aromatase inhibitors and tamoxifen therapy are applied during complete remission of invasive breast cancer to prevent the invasive cancer from recurring or distant metastasis. The cancer still may be in the body.#N#In remission generally is coded as current, as long as there is no contradictory information elsewhere in the record.#N#History of Cancer: The record describes cancer as historical or “history of” and/or the record states the current status of cancer is “cancer free,” “no evidence of disease,” “NED,” or any other language that indicates cancer is not current.#N#According to the National Cancer Institute, for breast cancer, the five-year survival rate for non-metastatic cancer is 80 percent. The thought is, if after five years the cancer isn’t back, the patient is “cancer free” (although cancer can reoccur after five years, it’s less likely). As coders, it’s important to follow the documentation as stated in the record. Don’t go by assumptions or averages.

What is the ICd 10 code for primary malignancy?

According to the ICD-10 guidelines, (Section I.C.2.m):#N#When a primary malignancy has been excised but further treatment, such as additional surgery for the malignancy, radiation therapy, or chemotherapy is directed to that site, the primary malignancy code should be used until treatment is complete.#N#When a primary malignancy has been excised or eradicated from its site, there is no further treatment (of the malignancy) directed to that site, and there is no evidence of any existing primary malignancy, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy.#N#Section I.C.21.8 explains that when using a history code, such as Z85, we also must use Z08 Encounter for follow-up examination after completed treatment for a malignant neoplasm. This follow-up code implies the condition is no longer being actively treated and no longer exists. The guidelines state:#N#Follow-up codes may be used in conjunction with history codes to provide the full picture of the healed condition and its treatment.#N#A follow-up code may be used to explain multiple visits. Should a condition be found to have recurred on the follow-up visit, then the diagnosis code for the condition should be assigned in place of the follow-up code.#N#For example, a patient had colon cancer and is status post-surgery/chemo/radiation. The patient chart notes, “no evidence of disease” (NED). This is reported with follow-up code Z08, first, and history code Z85.038 Personal history of other malignant neoplasm of large intestine, second. The cancer has been removed and the patient’s treatment is finished.

How old is the man who had a right hemiglossectomy?

This is an 86-year-old gentleman who underwent right hemiglossectomy with right supraomohyoid neck dissection on February 26, 2016. Postoperatively he states he is doing well and eating “everything that’s put in front of me”. He denies any difficulty with dysphagia.

How long does it take for breast cancer to go away?

According to the National Cancer Institute, for breast cancer, the five-year survival rate for non-metastatic cancer is 80 percent. The thought is, if after five years the cancer isn’t back, the patient is “cancer free” (although cancer can reoccur after five years, it’s less likely).

Does history of cancer affect relative value units?

The fear is, history of will be seen as a less important diagnosis, which may affect relative value units . Providers argue that history of cancer follow-up visits require meaningful review, examinations, and discussions with the patients, plus significant screening and watching to see if the cancer returns.

Is cancer history?

History of Cancer: The record describes cancer as historical or “history of” and/or the record states the current status of cancer is “cancer free,” “no evidence of disease,” “NED,” or any other language that indicates cancer is not current. According to the National Cancer Institute, for breast cancer, the five-year survival rate ...

Do providers look at cancer at the cellular level?

According to a presentation by James M. Taylor, MD, CPC, providers look at cancer at a cellular level; whereas, coding guidelines look more at the organ level. In his opinion, common concerns among providers are: Some neoplasms may not be active but remain at a cellular level, and can become active.

What is the Living with Cancer report?

Living with Cancer: A Report on the Patient Experience is the first in a series looking at Canadian cancer care exclusively from the patient perspective, illustrating the experience of those individuals and families living with and beyond cancer. This groundbreaking report includes data drawn from multiple sources, including Patient Reported Outcomes partners, the Ambulatory Oncology Patient Satisfaction Survey and initial results from the first Canada-wide study of cancer survivors on the experience of 13 000 Canadians with cancer ( Experiences of Cancer Patients in Transition Study ).

Why should clinicians have access to real time data?

Clinicians should have access to real-time data that informs their clinical decisions, to help ensure patients’ physical, emotional and practical needs are being met from cancer suspicion through to survivorship.

Who assesses cancer patients?

When patients with cancer participate in clinical trials of new therapies, it's usually the clinicians who assess and record the side effects that the patients experience. But a new study has found that patients, even those who are undergoing difficult treatments, are willing to devote time to completing thorough assessments ...

Why are patient reports not collected?

Overall, patient-reported outcomes were successfully collected at 86% of scheduled visits. The most common reasons that the data could not be collected were missed clinic appointments, simple oversights (such as forgetting to provide tablet computers to participants), and technical problems (such as computer malfunctions or Internet connectivity issues). Only 13% of missed reports occurred because patients felt too sick to fill out the forms.

What is the PRO-CTCAE system?

Researchers at NCI and at cancer centers across the United States set out to build a version of the CTCAE system to be used for self-reporting of symptomatic side effects by patients, called the PRO-CTCAE.

Why do we use CTCAE?

As part of their standard patient assessments, staff involved in trials use the CTCAE system to record any side effects patients are experiencing. But researchers have long wondered if creating a way for patients to document their own experiences during treatment would help to provide more complete and accurate information about symptomatic side effects that may be associated with new drugs or treatment regimens.

What is CTCAE in clinical trials?

This tool allows reports on everything from blood test values to toothaches. It also includes many symptoms—such as nausea, anxiety, and nerve pain—that are by their nature personal and difficult for an observer to measure.

How many side effects are there in CTCAE?

The team combed through the CTCAE to identify those adverse events that are amenable to self-reporting. They identified 78 symptomatic side effects that are associated with common treatments, including chemotherapy, radiation therapy, biological therapy, and immunotherapy, explained Sandra Mitchell, Ph.D., program director in NCI's Outcomes Research Branch and current scientific lead for PRO-CTCAE development. A library of questions phrased using plain, patient-friendly language was developed to capture these side effects directly from patients, Dr. Mitchell continued.

Why are there gaps in patient outcomes?

The study, in fact, found that most gaps in these patient-reported outcomes data—which were captured during clinic visits using tablet computers—weren't caused by patients feeling too ill to provide reports. Instead, they were due largely to technical errors like lost Internet connectivity.

Why is accurate reporting important?

Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. Authors are encouraged to adhere to the following research reporting standards.

Why is it important for a publisher to protect personal information?

The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed.

What information is required to submit a manuscript to a publisher?

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.

How many names of peer reviewers are required?

Authors are required to suggest at least three names of recommended peer reviewers and their email addresses. Authors can also indicate reviewers to exclude, with associated reasons. The editors reserve the right to accept or decline these requests.

How to respond to reviewer comments?

Response to Reviewers/Rebuttal letter - Please submit a separete document for detailed response to the previous set of editor and reviewer comments. The most robust approach is to copy the decision letter into a Word document and insert your responses beneath each comment, starting your text with “>>>”.

Where to list funding sources?

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/

When should an ethical statement be submitted?

Ethical Statement: Starting from submissions in February 1, 2020 , all eligible articles should have an explicit statement that includes information on ethical approvals and consent to participate and publish.

Is Cancer Reports open access?

We are pleased to announce that Cancer Reports joined Wiley’s Open Access portfolio as of January 2021. All articles published by Cancer Reports from August 13, 2020 are fully open access: immediately freely available to read, download and share and published under the terms of the Creative Commons Attribution License. Articles published before August 13, 2020 are also freely available. All submissions received from August 13, 2020 are subject to an Article Publication Charge if accepted and published in the journal. For more information on the fees, please click here.

Is SCR7 a cancer drug?

SCR7, a potent cancer therapeutic agent and a biochemical inhibitor of nonhomologous DNA end‐joining. Manjunath et al., highlight the anticancer effects of SCR7 as a single agent and in combination with other chemotherapeutic agents and radiation.

Section 1.C.2 Provides Guidance

• According to the ICD-10 guidelines, (Section I.C.2.m): When a primary malignancy has been excised but further treatment, such as additional surgery for the malignancy, radiation therapy, or chemotherapy is directed to that site, the primary malignancy code should be used until treatment is complete. When a primary malignancy has been excised or era...

See more on aapc.com

Defining Terms with Care

Active Treatment vs. Preventative Care

The Provider Perspective

“History Of” Doesn’T Mean A Lesser Service